Adar, Tomer <br/><br/>
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  04 2019 
 - 873-879 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.15177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Cohort Studies<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Inflammatory Bowel Diseases--diagnosis<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Treatment Outcome<br/>Tumor Necrosis Factor Inhibitors--therapeutic use